May 1, 2022

Brand Medications with Generic Alternatives Anticipated to be Approved in May

Read More
April 25, 2022

Veklury Approved to Treat COVID-19 in Younger Patient Population

Read More
April 22, 2022

Pfizer Recalls Five Lots of Accupril

Read More
April 21, 2022

Zerbaxa Now Indicated for Children

Read More
April 14, 2022

Single Batch of Lantus Generic Recalled

Read More
April 14, 2022

Imcivree Approved in Treatment of Two Rare Genetic Disorders

Read More
April 13, 2022

Avastin Biosimilar Alymsys Granted Approval

Read More
April 11, 2022

Xigduo XR Receives New Indication for Kidney Disease

Read More
April 8, 2022

ArmonAir Now Indicated for Younger Patient Population

Read More
April 6, 2022

Vijoice Approved to Treat Group of Rare Genetic Disorders

Read More
April 6, 2022

New Acute Treatment Option for Schizophrenia and Bipolar Disorder

Read More
April 4, 2022

Ardelyx Launches Irritable Bowel Syndrome Treatment Ibsrela

Read More